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INTRODUCTION. James H. Woods. University of Michigan, 
School of Medicine, Ann Arbor, MI. 
Excitatory amino acids are major neurotransmitters throughout 
the brain and spinal cord, Neuropharmacological advances have 
led to a division of their actions upon neurons through a charac- 
terization of different receptors. These receptors can now be 
assessed through the use of agonists and antagonists and inferences 
drawn about function through the selective actions that agonists 
and antagonists evoke. This symposium will demonstrate the 
various ways that behavioral pharmacology can play an important 
role in describing and analyzing these functions. 
DRUG DISCRIMINATION OF COMPETITIVE (CGS-19755) 
AND NONCOMPETITIVE (PHENCYCLIDINE) N-METHYL- 
D-ASPARTIC ACID ANTAGONISTS IN PIGEONS. J. David 
Leander. Lilly Research Laboratories, Eli Lilly and Co., Indian- 
apolis, IN. 
Pigeons were trained to discriminate 0.64 mg/kg IM of phen- 
cyclidine vs. vehicle or 1.25 mg/kg IM of CGS-19755 vs. vehicle 
under fixed-ratio 40-response schedules of reinforcement. The 
pretreatment times before the sessions began were 15 min for 
phencyclidine and 90 min for CGS-19755. The doses of the two 
training drugs have previously been shown to antagonize the 
behavioral suppressant effects of 10 mg/kg of N-methyl-D-aspartic 
acid in pigeons responding under a multiple FR-FI schedule of 
reinforcement. When competitive NMDA antagonists (AP-5, 
AP-7, etc.) were tested in birds trained to discriminate phency- 
clidine, there was no generalization to the phencyclidine cue, 
although noncompetitive antagonists (phencyclidine, MK-801, 
etoxadrol, dexoxadrol, etc.) were generalized. In birds trained to 
discriminate CGS-19755, both competitive and noncompetitive 
antagonists were generalized to the CGS-19755 cue in a dose- 
related fashion. These results suggest that noncompetitive antag- 
onists (i.e., phencyclidine) have subjective, discriminative effects 
that are not shared by competitive NMDA antagonists. However, 
the subjective, discriminative effects of competitive antagonists 
can be detected within the complex of discriminative effects 
produced by noncompetitive antagonists. 
EFFECTS OF EXCITATORY AMINO ACIDS ON ACQUISI- 
TION, RETENTION AND PERFORMANCE. J. M. Moersch- 
baecher, C. W. Berthold, P. Stevens, L. LaMotte and M. Pierson. 
Louisiana State University Medical Center, New Orleans, LA; and 
J. H. Woods. University of Michigan School of Medicine, Ann 
Arbor, MI. 
The effects of various excitatory amino acid agonists and 
antagonists were investigated in rats and monkeys responding 
under various discrimination procedures. In rats, NMDA produced 
a dose-dependent decrease in response rate, but had no effect on 
accuracy of the performance. In general, the noncompetitive 
antagonist phencyclidine (PCP) failed to antagonize the effects of 
NMDA. Similarly, the glycine analog d-cycloserine failed to 
antagonize the effects of PCP. Across a wide range of doses 
NMDA failed to enhance acquisition in either rats or monkeys 
responding under repeated acquisition procedures. Rather, at high 
doses, NMDA produced decreases in overall response rates which 
were antagonized by the competitive antagonist CGS 19755 in a 
dose-dependent manner. In monkeys, NMDA failed to enhance 
retention of a discrimination following either a 1-hr or 24-hr delay. 
At higher doses, however, NMDA decreased response rate and 
produced amnestic effects as evidenced by a decrease in percent 
savings. The amnestic effects of NMDA were antagonized by 
CGS 19755 at doses lower than those required to antagonize the 
rate-decreasing effects. 
N-METHYL-D-ASPARTATE AND KAINATE ARE POWER- 
FUL DIPSOGENS IN PIGEONS. S. P. Baron and J. H. Woods. 
University of Michigan, Ann Arbor, MI. 
During a previous study in which pigeons were trained to 
discriminate 5.6 mg/kg N-methyl-D-aspartate (NMDA) IM from 
saline it was observed that subjects that had received NMDA drank 
water more often than those that had received saline injections. A 
dose response to NMDA was then determined in six pigeons. 
Drinking over one hour reached a maximum following 10.0 mg/kg 
NMDA followed by a decrease after 18.0 mg/kg. Drinking after 
saline was considerably less than that produced by NMDA. 
Kainate was ten times more potent than NMDA in producing 
drinking. Water consumption reached a maximum at 1.0 mg/kg 
and was also followed by a slight decrease following 3.2 mg/kg 
kainate. Water consumption following NMDA or kainate admin- 
istration is approximately equivalent to that produced by 48-hour 
water deprivation. The proposed competitive NMDA antagonist 
CGS 19755 (Lehmann et al., J. Pharmacol. Exp. Ther. 245: 
65-75; 1988), when given as a 10-minute pretreatment (1.0 and 
3.2 mg/kg), modified the drinking-dose-response for both kainate 
and NMDA while producing no effect on deprivation-induced 
drinking. The changes in agonist-induced drinking by CGS 19755 
were different for NMDA and kainate. CGS 19755 produced an 
apparent antagonism of NMDA-induced drinking, but a marked 
increase (approximately 2-fold) in high-dose kainate-induced drink- 
ing. (This research was supported by NIDA grant DA-05325.) 
